December 20, 2021

Overjet Raises $42.5 Million Series B Following Explosive Customer Demand, Reaching $425 Million Valuation

BOSTONDec. 20, 2021 /PRNewswire/ — Amid accelerated demand for its dental artificial intelligence (AI) software, Overjet ( today announced it has raised $42.5 million in Series B financing led by General Catalyst and Insight Partners with participation from existing investors Crosslink Capital and the MIT-affiliated E14 Fund in an oversubscribed round. Following the $27 million Series A round announced, just four months ago, in August 2021, Overjet has raised nearly $80 million in total financing to date.

“Overjet’s cutting-edge software has seen incredible demand from clinicians and insurers alike who see our dental AI as a transformational technology to advance patient oral healthcare,” said Dr. Wardah Inam, PhD, CEO and co-founder of Overjet. “The new financing will accelerate our next chapter of growth to support our customers, grow the team, and invest in the next generation of technology to support patient care.”

Overjet’s dental AI technology encodes dentist-level understanding of disease identification and progression into software, supporting dentists to deliver the best patient care and insurers to operate more accurately and efficiently. Earlier this year, Overjet secured FDA clearance for its Dental AssistTM product, the first-ever dental AI company to receive such a clearance. The company is working with both large dental organizations and single-site clinics to roll out Dental Assist. In October, Overjet and New England Family Dentistry announced a partnership to bring dental AI to the organization’s 50 clinic network. Read rest here